Yilmaz E - Search Results

1

The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.

Oguzulgen IK, Yilmaz E, Demirtas S, Erkekol FO, Ekim N, Demir N, Numanoglu N, Ozel D, Ulu A, Akar N. Oguzulgen IK, et al. Among authors: yilmaz e. Clin Appl Thromb Hemost. 2009 Feb;15(1):73-7. doi: 10.1177/1076029607305110. Epub 2007 Dec 26. Clin Appl Thromb Hemost. 2009. PMID: 18160588 Free article.

2

Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and obesity.

Yilmaz E, Berberoglu M, Akar N. Yilmaz E, et al. Clin Appl Thromb Hemost. 2010 Feb;16(1):99-102. doi: 10.1177/1076029608323498. Epub 2008 Oct 7. Clin Appl Thromb Hemost. 2010. PMID: 18840627 Free article.

3

Effect of eNOS and ET-1 polymorphisms in thromboangiitis obliterans.

Adigüzel Y, Yilmaz E, Akar N. Adigüzel Y, et al. Among authors: yilmaz e. Clin Appl Thromb Hemost. 2010 Feb;16(1):103-6. doi: 10.1177/1076029609336854. Epub 2009 Jun 10. Clin Appl Thromb Hemost. 2010. PMID: 19520685 Free article.

4

Two new mutations at ERGIC-53 gene in a Turkish family.

Torun D, Yilmaz E, Atay A, Kürekçi E, Akar N. Torun D, et al. Among authors: yilmaz e. Clin Appl Thromb Hemost. 2011 Jun;17(3):248-50. doi: 10.1177/1076029609355153. Epub 2010 May 11. Clin Appl Thromb Hemost. 2011. PMID: 20460353 Free article.

5

Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A.

Akar N, Yilmaz E, Akar E, Avcu F, Yalçin A, Cin S. Akar N, et al. Among authors: yilmaz e. Thromb Res. 2000 Feb 15;97(4):227-30. doi: 10.1016/s0049-3848(99)00164-4. Thromb Res. 2000. PMID: 10674409

6

The role of prothrombotic mutations in patients with Buerger's disease.

Avcu F, Akar E, Demirkiliç U, Yilmaz E, Akar N, Yalçin A. Avcu F, et al. Among authors: yilmaz e. Thromb Res. 2000 Nov 1;100(3):143-7. doi: 10.1016/s0049-3848(00)00310-8. Thromb Res. 2000. PMID: 11108900

7

Plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation.

Akar N, Akar E, Yilmaz E, Deda G. Akar N, et al. Among authors: yilmaz e. J Child Neurol. 2001 Apr;16(4):294-5. doi: 10.1177/088307380101600413. J Child Neurol. 2001. PMID: 11332466

8

Factor V 1691 G-A mutation in children with intracardiac thrombosis: a prospective study.

Atalay S, Akar N, Tutar HE, Yilmaz E. Atalay S, et al. Among authors: yilmaz e. Acta Paediatr. 2002;91(2):168-71. doi: 10.1080/080352502317285162. Acta Paediatr. 2002. PMID: 11952004

9

Relationship between functional promoter polymorphism in the XBP1 gene (-116C/G) and atherosclerosis, ischemic stroke and hyperhomocysteinemia.

Yilmaz E, Akar R, Eker ST, Deda G, Adiguzel Y, Akar N. Yilmaz E, et al. Mol Biol Rep. 2010 Jan;37(1):269-72. doi: 10.1007/s11033-009-9674-4. Epub 2009 Aug 11. Mol Biol Rep. 2010. PMID: 19669932

10

Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells.

Karabiyik A, Güleç S, Yilmaz E, Haznedaroglu I, Akar N. Karabiyik A, et al. Among authors: yilmaz e. Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E165-70. doi: 10.1177/1076029610394437. Epub 2011 Mar 14. Clin Appl Thromb Hemost. 2011. PMID: 21406410 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,832 results

Search Page

Filters